Market Witnessing a Surge in Economical Drugs
Chapter 4 Atrial Fibrillation
Market, by Treatment Types 4.
The baseline atrial fibrillation
prevalence per 1,000 participants was increased in those older than 70 years (19.
For the present, all patients with chronic atrial fibrillation
should be considered candidates for long-term low-intensity warfarin therapy," cardiologist Daniel E.
Data presented in the abstract included: Beta blockers have modest efficacy for the prevention of atrial fibrillation
in chronic heart failure/reduced ejection fraction (HFREF) populations, with risk reductions on the order of 20-40%.
Levels in men averaged 141-142 U/dL regardless of whether they had atrial fibrillation
There are about 70,000 strokes [in the United States] each year related to atrial fibrillation
, and if we can prevent half of them, that's more than 100 strokes [prevented] per day," says Hart.
The Company is planning for the atrial fibrillation
trial to compare Gencaro to the beta-blocker metoprolol CR/XL in patients with the genotype (homozygous arginine position of the beta1389 adrenergic receptor) in which Gencaro appears to demonstrate therapeutic enhancement.
The duration of atrial fibrillation
was shorter in the prophylaxis group: 2 hours versus 18 hours.
The global atrial fibrillation
market is highly competitive with numerous small and large companies located throughout the world.
Andrea Natale, Executive Director for Texas Cardiac Arrhythmia Institute and Member of the Board of Trustees for GAFA said "I want to congratulate the members of the "Global Atrial Fibrillation
Alliance" for the incredible success of 'World Atrial Fibrillation
Awareness Day' in Kansas City and several other cities around the world.
Two months ago, he presented to the emergency department with atrial fibrillation
and a ventricular rate of 120 beats per minute.